secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001178913-25-003205
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion posts updated corporate presentation for H.C. Wainwright conference
----------------------------------------------------------------------------

- Updated corporate presentation posted to company website on September 2, 2025.
- Presentation to be presented on September 10, 2025 at H.C. Wainwright Global Investment Conference in New York.
- No specific financial or clinical data disclosed in the 8-K filing excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/0001178913-25-003205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/zk2533739.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-003205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer